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The development of an aorta-atrial fistula secondary to mechanical aortic valve infective 
endocarditis is a rare, serious complication. The fistula is an aberrant intra-cardiac shunt that 
occurs between the aorta and either the left or right atrium. 
 
An aorta-atrial fistula can be congenital or acquired. In the case of infective endocarditis, the 
infection’s expansion beyond the valvular structure may result in an aorto-cavitary fistula (ACF 
or AAF) with an estimated incidence of 1-2%.1 No clinical trials have been conducted for the 
best approach of management for this condition. Therefore, treatment strategies are applied on a 
case-by-case basis by expert opinion. Patients develop symptoms of heart failure secondary to 
AAF complications. The underlying cause of AAF needs to be identified with the use of imaging 
studies to determine the approach of optimal treatment.2 
 
We are reporting a case of a 32-year-old male with a history of repaired congenital heart disease, 
who developed mechanical aortic valve infective endocarditis from intravenous drug use with 









A 32-year-old male with a past medical history of congenital aortic stenosis presented to the 
hospital with two weeks of fever. At the age of 8, he underwent open aortic valvotomy with 
resection of a subaortic ring and myomectomy. Three years prior to the current presentation, he 
was diagnosed with severe aortic insufficiency and underwent re-entry median sternotomy, 
resection of the subaortic ring, left ventricular septal myotomy-myomectomy, reconstruction of 
left ventricular outflow tract with On-X 23 mm Dacron valve conduit, re-implantation of left and 
right coronary ostia, replacement of the ascending aorta, and tricuspid valve repair using a 32 
mm triad annuloplasty ring procedure. Gross description in the operative report disclosed 
findings of a bicuspid structural valve. On the pathology report, fibromyxoid degenerative 
changes of the valvular leaflets were found. 
 
At presentation to the outside facility, he had complaints of bilateral lower extremity weakness, 
vision changes, fever, chills, myalgias, and malaise for two weeks. Per patient report, he had 
used suboxone intravenously. The TEE showed an abscess with complete destruction of the left 
ventricular outflow track with a shunt of the LVOT to the left atrium, destruction of the aortic 
root, and a large anterior leaflet aortic valve vegetation. The CT head revealed bilateral occipital 
lobe hemorrhages and a large 3.7cm left occipital lobe hematoma. There was mass-effect and 
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cerebral edema, but no midline shift. Therefore, he was diagnosed with an ischemic stroke due to 
septic emboli with hemorrhagic conversion. His INR was supratherapeutic at 5.9, which was 
reversed after receiving KCENTRA and Vitamin K. He was seen by neurosurgery who 
recommended no surgical intervention and to hold anticoagulation. CT chest reported evidence 
of systemic embolization. Vancomycin was started with rifampin for synergy. The patient was 
transferred from the outside hospital to a higher level of care for evaluation by cardiothoracic 
surgery after being diagnosed with complicated MRSA mechanical aortic valve endocarditis. 
 
After cardiothoracic surgery evaluation, the TTE was repeated, which showed a fistula between 
the LVOT, proximal to AOV, and left atrium. The patient had a normal EF but the mechanical 
aortic valve was noted to have moderate to severe stenosis without regurgitation. A small aortic 
vegetation was also reported. For further evaluation, a TEE was performed which revealed 
restricted rocking, suggestive of valve dehiscence with moderate aortic regurgitation, and a large 
fistula between the aorta and left atrium (Figure 1-2). Also, a valve vegetation with a possible 
thrombus was noted. An aortic root vegetation and possible abscess was reported with no 
evidence of dissection. Infectious disease was consulted and adjusted antimicrobial therapy due 
to persistent MRSA bacteremia. After evaluation, the cardiothoracic surgeon decided that the 
patient was a poor surgical candidate and recommended to continue antibiotics and consult 
palliative care. 
 
Figure 1: Transesophageal echocardiogram view 1: LA left atrium, LV left ventricle, fistula 
between aorta and left atrium (yellow arrow). 
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The patient’s clinical condition began to deteriorate and show signs of acute CHF. He was 
transferred to the critical care unit due to worsening respiratory failure. Repeat TTE showed 
findings similar to previous findings with grade three diastolic heart failure. ProBNP was 5725, 
and a repeat CT chest revealed worsening bilateral pleural effusions. Intravenous diuretics were 
started, and thoracenteses were performed twice due to large pleural effusions. However, the 




An aorto-atrial fistula, caused by infective endocarditis, is due to the spread of the bacterial 
infection to the peri-valvular tissue. This leads to the destruction of the tissue and weakness of 
the wall integrity of the aorta and atrium, causing fistula formation.3 In a retrospective 
multicenter study, aorto-cavity fistula (ACF) is diagnosed in 1.6% of all cases of IE either 
identified by echocardiography or during surgery. A fistula was found in 1.8 % of cases of native 
valve IE, in 3.5% of prosthetic valves IE from the general population, and in 0.4% of IV drug 
Figure 2: Transesophageal echocardiogram view 2: doppler color flow from the aorta to the 
left atrium through the fistula (Yellow arrow). 
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abusers. Fistula formation only occurred in the aortic valves with IE and more frequently in 
prosthetic valves than native valves (5.8 vs. 3.6 % respectively).3 
 
In a retrospective, multi-center study, the most commonly isolated organism in fistula formation 
was the staphylococcus species, as seen in 58% of cases with prosthetic valve and 38 % with a 
native valve. Staphylococcus aureus was the most single common cause of fistula formation 
among patients with a native valve. Other pathogens included streptococcus spp. (33%), 
Enterococcus spp. (5%), and culture-negative pathogens (7%).3 
 
Imaging studies play a major role in the assessment of fistula. In a retrospective, descriptive, 
multi-center study, the TTE detected fistula formation in 53% of cases, but the TEE detected 
97% of cases, conveying the superiority of TEE over TTE.3 AAF usually occurs on the posterior 
aspect of the aorta, which is an area better delineated with the TEE than the TTE (1). Standard 
antimicrobial therapy and surgical intervention are the cornerstones of treating IE complicated by 
AAF. A high index of suspicion and early treatment of the fistula is crucial. Heart failure was 
observed in 62% of cases, and the in-hospital mortality was 41% (3). Heart failure is caused by 
the hemodynamic abnormality created by the shunt. Left ventricular function, however, can still 
remain normal.3 
 
Although acquired AAF is uncommon in patients with IE, with the increasing rates of IVDU in 
the US, the incidence of acquired AAF may increase. From 2002 to 2016, the reported rates of IE 
due to intravenous drug use have doubled.4 This case is unique, as the patient already had a 
congenital defect of his aortic valve requiring mechanical valve replacement, which was then 
complicated by IE from his IVDU. Patients with an intravenous substance use disorder, or with a 
history of underlying congenital heart disease or previous cardiac surgery who develop IE are 





An aorto-atrial fistula as the result of infective endocarditis is an uncommon complication. Early 
diagnosis, proper antibiotic treatment, and surgical intervention are crucial steps due to high 
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